• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*FX25RW
Device Problem Decrease in Pressure (1490)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/22/2020
Event Type  malfunction  
Manufacturer Narrative
Device expiration date - unknown due to unknown lot number.Implanted date: device was not implanted.Explanted date: device was not explanted.Device manufacturer date - unknown due to unknown lot number.Occupation- chief perfusionist.Pma/510(k)- k130520.The actual device has not been returned for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.The production lot number was not provided by the user facility, which prevented a meaningful review of the device history record.(b)(4).
 
Event Description
The user facility reported that the capiox device was used pre-treatment.Chief perfusionist: pressure alarm at a flow of 4.5 liters during the priming phase.Priming volumes: 1500ml jonosteril (carbohydrate electrolyte solution) 250ml / 15% mannitol solution 40ml / 8.4% sodium hydrogen carbonate 10.000 heparin complete hlm & set exchanged terumo tubing pack set: cxge272 / lot#: 2006330.The patient was not harmed.The procedure outcome was not reported.
 
Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation results.It was initially reported that the actual device was available for investigation; however, it was confirmed the device was not available.Therefore, sections d9 and h3 have been updated to reflect the device is not available.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.With no device return the exact cause of the reported event cannot be definitively determined based on the available information.
 
Manufacturer Narrative
This report is being submitted as follow up no.2.This reported event has been deemed not reportable based off the actual sample that was received on (b)(6) 2021.The product code was confirmed to not be cx*fx25rw as initially reported, and therefore is not reportable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key11192336
MDR Text Key280446572
Report Number9681834-2020-00273
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350701046
UDI-Public04987350701046
Combination Product (y/n)N
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 01/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/19/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCX*FX25RW
Was Device Available for Evaluation? No
Date Manufacturer Received06/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-